Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients

Table 3

Effect of type of antidiabetic treatment on CRC survival.

Variable	OS (months)	Crude HR	95% CI	Adjusted HR	95% CI
Non Diabetic	119	Ref	-	Ref	-
On metformin	153	0.74	0.46-1.20
Other treatment	29	2.18	1.31-3.63	2.11	1.19-3.75

Adjusted for age, sex, and cancer stage and tumor differentiation, cancer treatment, BMI, alcohol, and smoking, other treatment = insulin and/or other oral hypoglycemic agents, except metformin, and OS = overall survival.